Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice

您当前的位置：

首页 >

文章列表页 >

Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice

REVIEW | 更新时间：2023-02-28

上一篇|下一篇

- Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
- Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
- Natalie Yan-Lin Pang ，Alexander Shao-Rong Pang ，Vincent T. Chow ，De-Yun Wang
- 解放军医学杂志（英文版） 2022年9卷第2期页码：215-230
- 作者机构：
  1.Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
  2.Department of Microbiology and Immunology, National University of Singapore, Science Drive 2, Singapore 117545, Singapore
  3.Infectious Diseases Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
  4.Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore 119228, Singapore
- 作者简介：
  * micctk@nus.edu.sg;
  entwdy@nus.edu.sg
- 基金信息：
  the National Medical Research Council, Singapore(NMRC COVID19RF2-0002)
- DOI： 10.1186/s40779-021-00342-3
  中图分类号：
- 稿件说明：
移动端阅览
DOI：
DOI：

HTML全文
图( 1 ) 表( 1 )
参考文献
出版信息
数据统计

摘要

Abstract

关键词

Keywords

references

19

浏览量

18

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

BibTeX下载
Endnote下载
RefMan 下载
NoteExpress下载
NoteFirst下载

关联资源

相关文章

Advances in the design and development of SARS-CoV-2 vaccines

A cross-sectional study of olfactory and taste disorders among COVID-19 patients in China

Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID-19 in a Han Chinese population from Central China

Development of rapid advice guideline and standard and continuous updating guideline: experiences and practice

Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion

相关作者

Dai-Xu Wei

Xue-Liang Peng

Ji-Si-Yu Cheng

Hai-Lun Gong

Xiao-Hong Zhao

Zibiao Li

Meng-Di Yuan

Hu Yuan

相关机构

Institute of Materials Research and Engineering, A*STAR (Agency for Science, Technology and Research), 2 Fusionopolis Way, Innovis, #08-03

Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Medicine, Department of Life Sciences and Medicine, Northwest University

Department of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital Hainan Hospital

National Clinical Research Center for Otolaryngologic Diseases, No. 28 Fuxing Road

College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital